SOURCE: Market Foundations Inc.

June 20, 2012 09:00 ET

Where Opportunity Is Found - Research & Analysis on Abbott Laboratories and Amgen, Inc.

HONG KONG--(Marketwire - Jun 20, 2012) - This morning, announced new reports highlighting Abbott Laboratories (NYSE: ABT) and Amgen, Inc. (NASDAQ: AMGN). Free research downloads are available at

With markets in correction mode, investors are looking to quantify an accurate model, weighing positives and negatives of the months ahead. Upcoming negative pressures include China's slowdown, the European recession, the end of the Fed's Operation Twist stimulus program, continued geopolitical risks, election uncertainty, and potential 2013 budget bombshell of tax hikes and spending cuts. Meanwhile, positive offsets are driven by central banks (particularly China) cutting rather than hiking rates, deceleration in fuel and food prices, increase in consumer sentiment and resulting retail sales, signs of improvement in housing sales and new strength in auto production schedules.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Market Foundations is releasing new coverage on Abbott Laboratories for its current position within the healthcare industry. Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a range of health care products. Abbott operates in five segments: Proprietary Pharmaceutical Products, Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. The full research report on Abbott Laboratories (NYSE: ABT) is available here:

Market Foundations has released research on Amgen, Inc. for its changing role within the healthcare industry. Amgen Inc. (Amgen) is a biotechnology medicines company. The Company discovers, develops, manufactures and markets medicines for illnesses. It focuses solely on human therapeutics and concentrates on medicines based on cellular and molecular biology. The full research report on Amgen, Inc. (NASDAQ: AMGN) is available here:

About Market Foundations
By providing members with financial information services, we provide the foundation investors need to build investing intelligence. The difference between consistently making good investments or bad investments is nothing more than the right information at the right time.

Contact Information